FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
HENSEX Securities and Reliance Securities have given "Apply" recommendation to PKH Ventures IPO. Dilip Davda has given "May Apply" recommendation to PKH Ventures IPO. Capital Market has "Neutral" view about the IPO. Axis Capital has "Not Rated" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 2 | 1 | 1 | 0 | 1 |
% | 40.00 | 20.00 | 20.00 | 0.00 | 20.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Axis Capital![]() |
Not Rated | ![]() |
Capital Market![]() |
Neutral | ![]() |
Dilip Davda | May Apply | ![]() |
HENSEX Securities![]() |
Apply | ![]() |
Reliance Securities![]() |
Apply | ![]() |
The Captial Market (CapitalMarket.com) rating for PKH Ventures IPO is 40. Their analysis recommends Avoid, however active risk seekers can try for the IPO.
Reviewer | Rating Score | Rating |
---|---|---|
Capital Market | 40 | Avoid, however active risk seekers can try |
[Dilip Davda] PVL is engaged in construction/development, hospitality and management services and has thus varied operations. With the mix of business, it has improved its PAT margins for the reported periods. Based on its FY23 financial performance, the issue appears aggressively priced. Well-informed/cash surplus investors may consider an investment with a long-term perspective. Read detail review...
PKH Ventures IPO Reviews, analysis and views by popular members. Read PKH Ventures Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 1 | 0 | 2 | 4 |
% | 14.29 | 0.00 | 28.57 | 57.14 |
Member | Review |
---|---|
Nagros |
Apply for Long Term at Upper Price Band Involved in multiple businesses with improved PAT margins and should move in favour of investors in long-term July 4, 2023 12:10:35 PM |
IPOTraders ![]() |
Avoid Heavy debt July 3, 2023 3:43:40 PM |
ganga |
Avoid please avoid such type of mushroom companies. Those who have strong backing or in good field and having better prospect may be selected.m June 30, 2023 11:56:58 AM |
Crow ![]() |
Neutral No fancy in this company as it has no specialization or any other redeeming quality. Look for subscription and apply. July 3, 2023 12:15:38 PM |
Capital Investors |
Avoid RISKY BET June 30, 2023 10:52:00 AM |
Boring Investor (200+ Posts) |
Avoid Avoid June 30, 2023 11:38:31 AM |
B.M.SURANA ![]() |
Neutral Risky hai Mere hisaab se! |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|